Advertisement

Topics

Study opens new range of therapeutic options for patients with atypical Rett syndrome

04:50 EDT 4 Jul 2017 | News-Medical.net

A translational, multicenter study carried out by research groups of the Bellvitge Biomedical Research Institute, San Juan de Dios Hospital, the University of Barcelona, Clinic Hospital, the University of Vic, Santa Creu i Sant Pau Hospital and the thematic area of Rare Diseases, has unveiled the potential of D-serine -- a dietary supplement -- to improve the neuronal function of a patient with a mutation of the glutamate receptors associated to atypical Rett syndrome with severe encephalopathy.

Original Article: Study opens new range of therapeutic options for patients with atypical Rett syndrome

NEXT ARTICLE

More From BioPortfolio on "Study opens new range of therapeutic options for patients with atypical Rett syndrome"

Advertisement
Quick Search
Advertisement
Advertisement